Home » Topics » BioWorld Science

BioWorld Science
RSS

Novopharm authorized to market generic Prozac in same color

Oct. 4, 1996

Atypical antipsychotic receives approvals

Oct. 4, 1996

Genset and Johnson & Johnson collaborate in the area of schizophrenia

Oct. 4, 1996

New antipsychotic agents from Janssen

Oct. 4, 1996

5-HT2B/2C antagonists disclosed by SKB

Oct. 4, 1996

Novel benzodiazepine derivatives from Roche

Oct. 4, 1996

Introduction of integrated test for breast and ovarian cancer ahead of schedule

Oct. 4, 1996

Antex awarded SBIR grant for diagnostic tests

Oct. 4, 1996

Broad patent coverage for Sonus's ultrasound contrast agents

Oct. 4, 1996

Promising clinical results with gastrointestinal cancer diagnostic

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...